Subtype-selective Nav1.8 sodium channel blockers: Identification of potent, orally active nicotinamide derivatives was written by Kort, Michael E.;Atkinson, Robert N.;Thomas, James B.;Drizin, Irene;Johnson, Matthew S.;Secrest, Matthew A.;Gregg, Robert J.;Scanio, Marc J. C.;Shi, Lei;Hakeem, Ahmed H.;Matulenko, Mark A.;Chapman, Mark L.;Krambis, Michael J.;Liu, Dong;Shieh, Char-Chang;Zhang, XuFeng;Simler, Gricelda;Mikusa, Joseph P.;Zhong, Chengmin;Joshi, Shailen;Honore, Prisca;Roeloffs, Rosemarie;Werness, Stephen;Antonio, Brett;Marsh, Kennan C.;Faltynek, Connie R.;Krafte, Douglas S.;Jarvis, Michael F.;Marron, Brian E.. And the article was included in Bioorganic & Medicinal Chemistry Letters in 2010.Electric Literature of C8H8BrNO2 This article mentions the following:
A series of aryl-substituted nicotinamide derivatives with selective inhibitory activity against the Nav1.8 sodium channel is reported. Replacement of the furan nucleus and homologation of the anilide linker in subtype-selective blocker A-803467 (1) provided potent, selective derivatives with improved aqueous solubility and oral bioavailability. Representative compounds from this series displayed efficacy in rat models of inflammatory and neuropathic pain. In the experiment, the researchers used many compounds, for example, Ethyl 2-bromoisonicotinate (cas: 89978-52-9Electric Literature of C8H8BrNO2).
Ethyl 2-bromoisonicotinate (cas: 89978-52-9) belongs to pyridine derivatives. Pyridines are an important class of heterocycles and occur in polysubstituted forms in many naturally occurring biologically active compounds, drug molecules and chiral ligands. Pyridine, its benzo and pyridine-based compounds play diverse roles in organic chemistry. Pyridine-based materials are valued for their optical and physical properties as well as their medical potential. Electric Literature of C8H8BrNO2